SCHEMBL19014148

SCHEMBL19014148

COC(=O)c1cc2c(C)ccc(F)c2n1C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.39
CYP1A2 P05177 1/20 0.36
POLB P06746 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36
LMNA P02545 4/20 0.34
NPSR1 Q6W5P4 2/20 0.34
MAPT P10636 3/20 0.34
TP53 P04637 1/20 0.34
KDR P35968 1/20 0.34
TSHR P16473 2/20 0.34
NOTUM Q6P988 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
GABRG2 P18507 2/20 0.33
GABRB3 P28472 2/20 0.33
GABRA5 P31644 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KDM4E B2RXH2 3/20 0.32
LDHA P00338 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18990513 0.87 NR1H2 (0.38) NR1H2CYP1A2CYP3A4CYP2C19LMNA
SCHEMBL19014232 0.85 MEN1 (0.40) NR1H2CYP1A2POLBCYP3A4CYP2C19
SCHEMBL19013556 0.81 NR1H2 (0.39) NR1H2LMNAMAPTTSHRL3MBTL1
SCHEMBL29631908 0.81 NR1H2 (0.39) NR1H2LMNAMAPTTSHRL3MBTL1
SCHEMBL25307868 0.81 NR1H2 (0.38) NR1H2CYP1A2CYP3A4CYP2C19MAPT
SCHEMBL30462966 0.79 NR1H2 (0.37) NR1H2CYP1A2POLBCYP3A4CYP2C19
SCHEMBL25308959 0.79 NR1H2 (0.37) NR1H2CYP1A2POLBCYP3A4CYP2C19
SCHEMBL2133036 0.78 CHRM2 (0.41) NR1H2GABRG2GABRB3GABRA5L3MBTL1
SCHEMBL29631893 0.78 NR1H2 (0.40) NR1H2CYP1A2POLBCYP3A4CYP2C19
SCHEMBL29631921 0.78 CHRM2 (0.41) NR1H2GABRG2GABRB3GABRA5L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017106352-A1 CAFFEINE INHIBITORS OF MTHFD2 AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-06-22 WO disclosed